Concepedia

Vincenzo Ricci

VR

16

Publications

699

Citations

14

H-Index

2008

Active since

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

Azienda Ospedaliera Universitaria Pisana

Istituti Ospitalieri di Cremona

University of Pisa

University of Urbino

Vincenzo Ricci is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, oncology, and colorectal cancer.

ORCID

Top concepts

Publications per year

2008–2023

16

Publications

16

Immunological Effects of Bevacizumab-Based Treatment in Metastatic Colorectal Cancer

M. Manzoni, B. Rovati, Monica Ronzoni et al. · Oncology · 2010 · 88 citations

Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer

Fotios Loupakis, Annamaria Ruzzo, Lisa Salvatore et al. · BMC Cancer · 2011 · 74 citations · Full text

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

Joris van de Haar, Xuhui Ma, Salo Ooft et al. · Nature Medicine · 2023 · 74 citations · Full text

Erlotinib: an EGF receptor tyrosine kinase inhibitor in non-small-cell lung cancer treatment

Clorinda Schettino, Maria Anna Bareschino, Vincenzo Ricci et al. · Expert Review of Respiratory Medicine · 2008 · 70 citations

, , +12

Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients

Annamaria Ruzzo, Francesco Graziano, Fabio Galli et al. · British Journal of Cancer · 2017 · 68 citations · Full text

Rows per page

1–5 of 16